IQVIA Holdings (IQV) recently forged a strategic partnership with Kexing Biopharm, aiming to bolster the clinical development and market integration of innovative therapeutics globally. Over the last ...

What Happened? A number of stocks jumped in the afternoon session after positive inflation data fueled hopes for an interest ...

Shares of Gartner Inc. advanced 5.78% to $242.66 Wednesday, on what proved to be an all-around positive trading session for ...

IQVIA Holdings stock surged on Tuesday after the clinical research and analytics company's second-quarter results topped ...

See the latest IQVIA Holdings Inc stock price (IQV:XNYS), related news, valuation, dividends and more to help you make your investing decisions.

Shares of IQVIA Holdings Inc. IQV slipped 2.97% to $185.86 Thursday, on what proved to be an all-around rough trading session ...

IQVIA has seen an increase of 58.97% in its revenues since 2017. In addition, its net profit margin has strengthened since 2018. The CRO market expects to grow at a 7.42% CAGR between 2024 and ...

He joined IQVIA in 2003 and has been rising up the ranks ever since, from director of stats to leading a team over more than 50 to incorporate artificial intelligence into the company’s suite of ...

Iqvia Holdings Inc. IQV 3.62% is hardly a household name, but its boss made more last year than the chief executive of Johnson & Johnson —or any other big pharmaceutical or biotech company.